Inventor

HOFFMAN AMNON

IL11 patents

⚠️ This page may combine multiple inventors who share the name “HOFFMAN AMNON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD

3 patents

US11261215B2Mar 1, 2022

Somatostatin prodrugs

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations53

US10662225B2May 26, 2020

Backbone cyclized inhibitory peptides of myeloid differentiation factor 88 (MyD88)

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations48

US12161763B2Dec 10, 2024

Formulation and method for increasing oral bioavailability of drugs

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations42

YISSUM RES DEV CO

2 patents

US6399086B1Jun 4, 2002

Pharmaceutical preparations for the controlled release of beta-lactam antibiotics

YISSUM RES DEV CO58 citations94

US6685962B2Feb 3, 2004

Gastroretentive controlled release pharmaceutical dosage forms

YISSUM RES DEV CO128 citations93

UNIV MICHIGAN REGENTS

2 patents

US9725484B2Aug 8, 2017

Methods and compositions for the treatment of bone remodeling disorders

UNIV MICHIGAN REGENTS0 citations50

US9555086B2Jan 31, 2017

Compositions and methods for inducing an immune response

UNIV MICHIGAN REGENTS0 citations47

HOLOSHITZ JOSEPH

1 patent

US8658603B2Feb 25, 2014

Compositions and methods for inducing an immune response

HOLOSHITZ JOSEPH6 citations74

FRIEDMAN MICHAEL

1 patent

US11052043B2Jul 6, 2021

Sustained-release injectable formulation

FRIEDMAN MICHAEL1 citations59

UNIV MUENCHEN TECH

1 patent

US11965041B2Apr 23, 2024

N-methylated cyclic peptides and their prodrugs

UNIV MUENCHEN TECH0 citations38

BREUER ELI

1 patent

US8993544B2Mar 31, 2015

Carbamoylphosphonates as inhibitors and uses thereof

BREUER ELI0 citations24